Clareo Health | Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Forest Laboratories
With
Phenomix
Age
18–86
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have successfully completed all required visits of a qualifying Phase 3 core protocol
Be currently receiving treatment for T2DM as set forth in the qualifying Phase 3 core protocol
You may not be if
Any condition, disease, disorder or clinically relevant laboratory abnormality which, in the opinion of the investigator, would jeopardize the patient's appropriate participation in this study or obscure the effects of treatment
